PREFERENCES OF PATIENTS WITH RHEUMATOID ARTHRITIS REGARDING DISEASE MODIFYING ANTIRHEUMATIC DRUGS: A DISCRETE CHOICE EXPERIMENT

被引：0
|
作者：
Van Heuckelum, M. [1 ]
Mathijssen, E. [2 ]
Vervloet, M. [3 ]
Boonen, A. [4 ]
Pasma, A. [5 ]
Hebing, R. [6 ]
Vonkeman, H. [7 ]
Wenink, M. [2 ]
van den Bemt, B. [1 ]
van Dijk, L. [3 ]
机构：
[1] Sint Maartensklin, Rheumatol & Pharm, Nijmegen, Netherlands
[2] Sint Maartensklin, Rheumatol, Nijmegen, Netherlands
[3] NIVEL, Utrecht, Netherlands
[4] MUMC, Rheumatol, Maastricht, Netherlands
[5] ErasmusMC, Rheumatol, Rotterdam, Netherlands
[6] Reade, Rheumatol, Amsterdam, Netherlands
[7] MST, Rheumatol, Enschede, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.2906
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0281-HPR
引用
收藏
页码：188 / 189
页数：2
相关论文
共 50 条
  • [21] Corticosteroids and disease-modifying antirheumatic drugs for coronavirus disease 2019 in patients with rheumatoid arthritis
    Chen, Yu-Han
    Lee, Yuan-Ti
    Ma, Kevin Sheng-Kai
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (07) : 1391 - 1392
  • [22] Treatment Preferences of Patients with Early Rheumatoid Arthritis: A Discrete-Choice Experiment
    Hazlewood, Glen S.
    Bombardier, Claire
    Tomlinson, George A.
    Thorne, Carter
    Bykerk, V. P.
    Thompson, Andrew
    Tin, Diane
    Marshall, Deborah
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [23] Treatment Preferences of Patients with Early Rheumatoid Arthritis: A Discrete-Choice Experiment
    Hazlewood, Glen
    Marshall, Deborah
    Tomlinson, George
    Thorne, Carter
    Thompson, Andrew
    Bykerk, Vivian
    Tin, Diane
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1265 - 1266
  • [24] Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment
    Hazlewood, Glen S.
    Bombardier, Claire
    Tomlinson, George
    Thorne, Carter
    Bykerk, Vivian P.
    Thompson, Andrew
    Tin, Diane
    Marshall, Deborah A.
    RHEUMATOLOGY, 2016, 55 (11) : 1959 - 1968
  • [25] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis
    Di Munno, O
    Delle Sedie, A
    Rossini, A
    Adamil, S
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 137 - 144
  • [26] THE USE OF DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN THE MANAGEMENT OF RHEUMATOID-ARTHRITIS
    HART, LE
    TUGWELL, P
    POSTGRADUATE MEDICAL JOURNAL, 1989, 65 (770) : 905 - 912
  • [27] Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis
    Aletaha, D
    Kapral, T
    Smolen, JS
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (05) : 482 - 486
  • [28] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [29] TOXICITY PROFILES OF DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS
    SINGH, G
    FRIES, JF
    WILLIAMS, CA
    ZATARAIN, E
    SPITZ, P
    BLOCH, DA
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (02) : 188 - 194
  • [30] Cost effectiveness analysis of disease modifying antirheumatic drugs in rheumatoid arthritis
    Manathip Osiri
    Pirom Kamolratanakul
    Andreas Maetzel
    Peter Tugwell
    Rheumatology International, 2007, 27 : 1063 - 1069
12345